These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 14729469

  • 1. Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis.
    Di Stefano V, Rinaldo C, Sacchi A, Soddu S, D'Orazi G.
    Exp Cell Res; 2004 Feb 15; 293(2):311-20. PubMed ID: 14729469
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R, Nardinocchi L, Pistritto G, D'Orazi G.
    Gynecol Oncol; 2008 Jun 15; 109(3):403-10. PubMed ID: 18395248
    [Abstract] [Full Text] [Related]

  • 3. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V, Soddu S, Sacchi A, D'Orazi G.
    Oncogene; 2005 Aug 18; 24(35):5431-42. PubMed ID: 15897882
    [Abstract] [Full Text] [Related]

  • 4. HIPK2 modulates p53 activity towards pro-apoptotic transcription.
    Puca R, Nardinocchi L, Sacchi A, Rechavi G, Givol D, D'Orazi G.
    Mol Cancer; 2009 Oct 14; 8():85. PubMed ID: 19828042
    [Abstract] [Full Text] [Related]

  • 5. HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function.
    Di Stefano V, Blandino G, Sacchi A, Soddu S, D'Orazi G.
    Oncogene; 2004 Jul 01; 23(30):5185-92. PubMed ID: 15122315
    [Abstract] [Full Text] [Related]

  • 6. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation.
    Rui Y, Xu Z, Lin S, Li Q, Rui H, Luo W, Zhou HM, Cheung PY, Wu Z, Ye Z, Li P, Han J, Lin SC.
    EMBO J; 2004 Nov 24; 23(23):4583-94. PubMed ID: 15526030
    [Abstract] [Full Text] [Related]

  • 7. The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage.
    Reuven N, Adler J, Porat Z, Polonio-Vallon T, Hofmann TG, Shaul Y.
    J Biol Chem; 2015 Jul 03; 290(27):16478-88. PubMed ID: 25944899
    [Abstract] [Full Text] [Related]

  • 8. Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis.
    Cecchinelli B, Lavra L, Rinaldo C, Iacovelli S, Gurtner A, Gasbarri A, Ulivieri A, Del Prete F, Trovato M, Piaggio G, Bartolazzi A, Soddu S, Sciacchitano S.
    Mol Cell Biol; 2006 Jun 03; 26(12):4746-57. PubMed ID: 16738336
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations.
    Di Stefano V, Mattiussi M, Sacchi A, D'Orazi G.
    FEBS Lett; 2005 Oct 24; 579(25):5473-80. PubMed ID: 16212962
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response.
    Petroni M, Veschi V, Prodosmo A, Rinaldo C, Massimi I, Carbonari M, Dominici C, McDowell HP, Rinaldi C, Screpanti I, Frati L, Bartolazzi A, Gulino A, Soddu S, Giannini G.
    Mol Cancer Res; 2011 Jan 24; 9(1):67-77. PubMed ID: 21173028
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response.
    Mancini F, Pieroni L, Monteleone V, Lucà R, Fici L, Luca E, Urbani A, Xiong S, Soddu S, Masetti R, Lozano G, Pontecorvi A, Moretti F.
    Oncogene; 2016 Jan 14; 35(2):228-40. PubMed ID: 25961923
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.